Relationships of B-cell Activating Factor Gene Polymorphisms With Crohn's Disease.

计划入组 824 人 · 首次发布于 2026 年 2 月 4 日

BAFF/APRIL in Kidney Transplant Rejection Risk Assessment

计划入组 176 人 · 首次发布于 2023 年 3 月 22 日

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

计划入组 27 人 · 首次发布于 2024 年 1 月 5 日

Platelet Activating Factor

C₂₆H₅₄NO₇P

BAFFR-CAR T cell therapy (PeproMene Bio Inc)

T-cell activating DARPins

MAGNESIUM FACTOR PTY LTD

Australia

AB&B BIO-TECH-B

MOTHER SUN PROTECTION FACTOR PTY LTD

Australia

Aurinia Pharmaceuticals Initiates Phase Ia Trial of AUR200 for Autoimmune Diseases

Lilly's Jaypirca Shows Promise in BTK Inhibitor-Pretreated CLL/SLL

Aurinia Settles Patent Litigation with Teva, Securing U.S. Exclusivity for LUPKYNIS Until 2036